Tracking Malaria Drug Resistance in Ghana
Official title: Geo-enabled detect and respond system for antimalarial resistance in Ghana: GDRS - Ghana
Funded at Institute of Human Virology · NIH-11087636 · Data updated 2026-11-12
This project aims to create a better way to find and respond to malaria that is becoming resistant to medicines in Ghana.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Institute of Human Virology NIH-funded |
| Lab location | 1 site (Abuja, Nigeria) |
| Project start | February 23, 2024 |
| Project end | May 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $249,928 |
| NIH project number | 5U01TW012531-04 |
| Project ID | NIH-11087636 on NIH RePORTER |
Who could benefit from this research
✓Could help
People living in communities in Ghana and other parts of Africa affected by malaria, especially those who might provide blood samples for surveillance, are relevant to this work.
✕Less likely to help
Patients outside of malaria-endemic regions or those not directly impacted by antimalarial drug resistance may not directly benefit from this specific surveillance effort.
What this research studies
Malaria is a serious health challenge, and medicines sometimes stop working as the parasite changes. This project will build a stronger network in Ghana to quickly spot when malaria drugs are no longer effective. Researchers will collect blood samples from communities and combine this information with other health data. This helps us understand how malaria is changing and allows health officials to respond faster to protect people.
Why it matters
Potential benefit: If successful, this work could help protect the effectiveness of current malaria treatments and guide the development of new medicines and vaccines, ultimately saving lives.
How similar studies have gone: Molecular markers are already recognized as useful tools for monitoring antimalarial drug resistance, and this project builds upon existing genomic surveillance networks.
Where this research is happening
-
Institute of Human Virology
Abuja, Nigeria Active
Researchers
- Principal investigator: Abimiku, Alash'le G. — Institute of Human Virology
- Study coordinator: Abimiku, Alash'le G.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.